Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for students already enrolled in this course.If you are a new student interested in enrolling, you can find information about the course of study on the course page:
Laurea magistrale in Molecular and Medical Biotechnology - Enrollment from 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
One course to be chosen among the followingOne course to be chosen among the following2 courses to be chosen among the following3 courses to be chosen among the following2° Year activated in the A.Y. 2018/2019
| Modules | Credits | TAF | SSD |
|---|
2 courses to be chosen among the following| Modules | Credits | TAF | SSD |
|---|
One course to be chosen among the followingOne course to be chosen among the following2 courses to be chosen among the following3 courses to be chosen among the following| Modules | Credits | TAF | SSD |
|---|
2 courses to be chosen among the followingLegend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Farming molecolare (2018/2019)
Teaching code
4S003677
Teacher
Coordinator
Credits
6
Language
English
Scientific Disciplinary Sector (SSD)
BIO/15 - PHARMACEUTICAL BIOLOGY
Period
I semestre dal Oct 1, 2018 al Jan 31, 2019.
Learning outcomes
The course aims to give the students notions of the use of recombinant systems for the production of biopharmaceuticals. In particular, the course will be focused on the biomolecular techniques used for the expression of recombinant proteins in prokaryotic and eukaryotic systems and the downstream processing and purification for their large-scale production. The different platforms used for the recombinant expression will be studied and compared. The different US and EU normative procedures for biopharmaceutical commercialization will be evaluated and compared, starting from pre-clinical studies. Specific examples of biopharmaceutical produced in recombinant systems and their therapeutic applications like for vaccines and antibodies will be discussed and studied.
Program
1) Definition of a biopharmaceutical, comparison with synthetic drugs and botanical drugs.
2) Clinical development of a biopharmaceutical and IP role.
3) Platforms used for the production of a biopharmaceutical (cellular lines and whole organisms). Methods for the production of recombinant proteins using: bacterial cells, yeasts, plant cellular lines, insect and mammalian cells, transgenic plants and animals.
4) Classes of biopharmaceuticals: vaccines, hormones and antibodies; therapeutic applications and production systems.
5) Techno-economical analysis of the production of a biopharmaceutical
Examination Methods
The final exam consists in an oral test on the topics of the course and on a written report on a specific biopharmaceuticals, covering both its production platform/s and its therapeutic use.
